Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v21-FR Version v16-EN
Language French English
Date Updated 2022-07-12 2022-06-18
Drug Identification Number 02410664 02410664
Brand name MYLAN-TADALAFIL MYLAN-TADALAFIL
Common or Proper name TADALAFIL TADALAFIL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients TADALAFIL TADALAFIL
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 4 BL 4 BL
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2022-05-03 2022-05-03
Actual start date 2022-05-03 2022-05-03
Estimated end date 2022-07-12 2022-07-19
Actual end date 2022-07-11
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments